Breadcrumb Home IMPAACT News IMPAACT News News July 2024 Meetings Register for the 2024 IMPAACT Annual Meeting July 2024 Spotlight Series Social Behavioral Scientific Core (SBSC) Spotlight Series: August 2024 July 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data Search Enter a search term. Filter Topics AllAnnouncementsMeetingsSpotlight SeriesStudy Results Date All202420232022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 88 news items. June 2020 Study Results IMPAACT P1093 Informs FDA Decision to Approve First-ever Dolutegravir Dispersible Tablet for Treatment of Children living with HIV June 2020 Announcements Statement from IMPAACT Leadership on Longstanding Racial Injustice March 2020 Meetings COVID-19 Resources March 2020 Study Results IMPAACT 2001 Primary Results Released March 2020 Study Results IMPAACT 2010 Primary Results Released March 2020 Study Results IMPAACT 2009 PK Results Released February 2020 Announcements IMPAACT 2016 Expert Trainer Training Underway December 2019 Study Results Results from P1104s published in Clinical Infectious Diseases October 2019 Study Results Primary results from the IMPAACT P1078/TB APPRISE study published August 2019 Announcements Indo-JHU clinical research team convenes first PHOENIx study community sensitization workshop for Maharashtra’s state government TB control program supervisors Pagination Previous page Prev Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Next page Next
July 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data
June 2020 Study Results IMPAACT P1093 Informs FDA Decision to Approve First-ever Dolutegravir Dispersible Tablet for Treatment of Children living with HIV
August 2019 Announcements Indo-JHU clinical research team convenes first PHOENIx study community sensitization workshop for Maharashtra’s state government TB control program supervisors